MAPT and Alzheimer disease: In the present study, we treated the human neuroblastoma SK-N-SH cells with wortmannin and GF-109203X, the classical activator of GSK-3β, to induce AD-like tau hyperphosphorylation, and investigated the effects and mechanisms of CIG on tau phosphorylation.